Rochester, NY 8/27/2009 3:39:16 PM
Achillion Pharmaceuticals, Inc. (ACHN) Ended the Yesterday’s Trading Session with a 5.96% Gain
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company specializing in commercialization of treatments for infectious diseases, gains 5.96% after market yesterday. The company, Opening at 1.71, spike up only at .04 with a total volume of 14,947.00 shares.
ACHN was founded in 1998 and is based in New Haven, Connecticut.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 1.78
Day's Range: 1.68 - 1.78
52wk Range: 0.65 - 2.78
Change: Up 0.10 (5.96%)
Volume: 14,947.00
Avg Vol (3m): 28,000.00
ABOUT Achillion Pharmaceuticals, Inc.,
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C and HIV infection; and the development of antibacterials for the treatment of resistant bacterial infections. Its products include ACH-1095, a NS4A antagonist that is in late-stage preclinical studies for the treatment of chronic hepatitis C infections; ACH-1625, a protease inhibitor, which is in the preparation for phase I initiation for the treatment of chronic hepatitis C infections; ACH-702, a preclinical candidate that is in preclinical stage with potency against a spectrum of bacterial pathogens, including methicillin-resistant staphylococcus aureus for drug resistant bacterial infections; and Elvucitabine, which completed phase II studies for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for use in treating hepatitis C infection, which inhibit viral replication through a mechanism of action. The company was founded in 1998 and is based in New Haven, Connecticut.
About StockEinstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
